BTL Creates New Laser Division, Launches EXOLASE ONE® Device
Medical and aesthetic technology company BTL has established a new division dedicated to laser technology. The company is also launching EXOLASE ONE®, described as the world's first "fused" erbium laser.
BTL, a company specializing in medical and aesthetic technologies, has announced the creation of a new division focused exclusively on laser technology. Concurrently, the company has launched EXOLASE ONE®, which it describes as the world's first "fused" erbium laser.
The new device utilizes a proprietary technology that merges multiple wavelengths into a single beam, aiming to set a new standard in laser-based facial rejuvenation. BTL states this approach allows for a more refined and effective treatment for skin renewal.
BTL operates as a global entity in the field of advanced medical and aesthetic technologies. The company's focus is on developing and delivering cutting-edge solutions for both therapeutic and cosmetic applications.
The introduction of EXOLASE ONE® signifies BTL's ongoing commitment to advancing laser capabilities within the aesthetics industry.